HeartLogic™
Predictive AI diagnostic for heart failure monitoring.
The first FDA-approved predictive analytic alert in an implantable device. It uses multiple sensor inputs to predict 70% of heart failure events approximately 34 days in advance.
PROS
- + FDA-approved and NICE-recommended diagnostic.
- + Predicts 70% of heart failure events in advance.
- + Provides a median of 34 days of lead time for clinical intervention.
- + Uses a multi-sensor algorithm for comprehensive physiological monitoring.
CONS
- - Requires implantation of a Boston Scientific ICD or CRT-D device.
- - Does not predict 100% of heart failure events
- - Access and cost are dependent on medical device coverage and hospital systems.
-
Proactively adjusting heart failure medication
-
early scheduling of follow-up patient visits
-
reducing hospital readmissions for heart failure patients
-
identifying high-risk heart failure patients remotely
SIMILAR TOOLS
Claude Healthcare
Claude helps healthcare organizations move faster without sacrificing accuracy, safety, or compliance. Less administrative work, more time with the people you serve.
ChatGPT Health
A dedicated experience in ChatGPT designed for health and wellness.
Verily
Precision health platform for research and patient care.
Medtronic (AI Surgery & Diabetes)
AI integrated into surgical robotics and chronic disease.